Allogeneic CD19 CAR-T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Allogeneic CD19 CAR-T cells, covering 2021-12-03 to 2021-12-20. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]